Verrica Pharmaceuticals (VRCA) Proxy filing summary

Executive summary

• Annual meeting scheduled for June 5, 2026, at company headquarters in West Chester, PA.

• Shareholders are invited to vote on key proposals, including director elections and executive compensation.

Voting matters and shareholder proposals

• Election of two directors: Paul B. Manning and Lawrence Eichenfield.

• Advisory vote on the compensation of named executive officers.

• Ratification of KPMG LLP as independent auditor for fiscal year ending December 31, 2026.

• Approval of the Amended and Restated 2018 Equity Incentive Plan.

• Other business may be addressed as appropriate during the meeting.

Board of directors and corporate governance

• Board recommends voting in favor of all proposals, including director nominees and compensation matters.